SLC27A2 and Hyperglycemia: Figure 5B demonstrates transient alanine-stimulated glucose increases in WT and FATP2-KO db/db mice, whereas db/db mice experienced sustained hyperglycemia (>600 mg/dL) from 30–120 minutes.